Trials / Completed
CompletedNCT00769821
The Impact of Lymphedema on Breast Cancer Survivors
The Impact of Lymphedema on Local and Overall Functioning
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 145 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Gathering information from breast cancer survivors about lymphedema; its symptoms and their impact on shoulder, arm, and hand functioning; and quality of life may help doctors learn more about the disease. PURPOSE: This clinical trial is studying the impact of lymphedema on breast cancer survivors.
Detailed description
OBJECTIVES: * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, and local upper extremity functioning. * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, local upper extremity functioning, and overall health-related functioning. * To determine the relationship between degree of lymphedema, lymphedema-associated symptoms, local upper extremity functioning, overall health-related functioning, and quality of life. OUTLINE: Patients are stratified according to presence of lymphedema (yes vs no). Patients complete self-reporting questionnaires to assess the degree of lymphedema using the Norman Questionnaire and Jane M. Armer's Lymphedema and Breast Cancer Questionnaire; lymphedema-associated symptoms using Symptoms in the Affected Breast/Mastectomy site questionnaire, Symptoms in the Shoulder, Arm, or Hand on the Affected Side questionnaire, and General Symptom Experience questionnaire; local upper extremity functioning using hand dominance questionnaire and the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire; quality of life (QOL) using the Multidimensional QOL Scale; and comorbidity using the Charleston Comorbidity Scale. Patients undergo a 3.5-hour testing to assess the degree of lymphedema by arm circumference and bioimpedance spectroscopy (BIS); local upper extremity functioning by strength testing, range of movement and neurodynamic testing using a goniometer, a skin examination, skin sensation and sensation at scar using the Semmes-Weinstein Monofilament test, and fine motor control/finger coordination using the Purdue Pegboard, Finger Tapper, and Vibration Threshold; and overall health-related functioning using a graded exercise test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire administration | |
| PROCEDURE | assessment of therapy complications | |
| PROCEDURE | bioimpedance spectroscopy | |
| PROCEDURE | quality-of-life assessment |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-10-09
- Last updated
- 2012-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00769821. Inclusion in this directory is not an endorsement.